MedTrace Logo

Post-Operative Treatment With Ketorolac After Abdominal Myomectomy

NCT00845754 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2009-02-18

No results posted yet for this study

Summary

The purpose of this study is to determine if ketorolac, given after abdominal myomectomy, will decrease the frequency of post-oerative fevers as well as improve post-operative pain management.

Conditions

  • Febrile Morbidity
  • Pain

Interventions

DRUG

ketorolac

15mg IV every6 hours for 4doses

DRUG

saline

15mg IV every 6hrs for 4 doses

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1999-09-30
Primary Completion
2001-08-31
Completion
2001-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00845754 on ClinicalTrials.gov